American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases

Gastroenterology

Volumn 152, Issue 6, 2017, Pages 1544-1577

  Singh, Siddharth ^a   Muir, Andrew J ^b   Dieterich, Douglas T ^c   Falck Ytter, Yngve T ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

Chronic Liver Diseases; Fibrosis; Guidelines; Noninvasive Imaging

Indexed keywords

ALCOHOL LIVER DISEASE; ARTICLE; CHRONIC HEPATITIS C; CHRONIC LIVER DISEASE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE COURSE; ELASTOGRAPHY; HEPATITIS B; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER STIFFNESS; MAGNETIC RESONANCE ELASTOGRAPHY; MORBIDITY; MORTALITY; NONALCOHOLIC FATTY LIVER; NONHUMAN; OUTCOME ASSESSMENT; PORTAL HYPERTENSION; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; RISK FACTOR; SUSTAINED VIROLOGIC RESPONSE; VIBRATION CONTROLLED TRANSIENT ELASTOGRAPHY; BIOPSY; BLOOD; CHRONIC HEPATITIS B; CLINICAL DECISION MAKING; COMPLICATION; DIAGNOSTIC IMAGING; ELASTICITY; ESOPHAGEAL AND GASTRIC VARICES; EVIDENCE BASED MEDICINE; LIVER; PATHOLOGY; PROCEDURES; RISK ASSESSMENT;

BIOPSY; CLINICAL DECISION-MAKING; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; ESOPHAGEAL AND GASTRIC VARICES; EVIDENCE-BASED MEDICINE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER DISEASES, ALCOHOLIC; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK ASSESSMENT;

EID: 85018815697     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2017.03.016     Document Type: Article

References (122)

1. 1 GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990−2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385 (2015), 117–171.
2. 2 Asrani, S.K., Larson, J.J., Yawn, B., et al. Underestimation of liver-related mortality in the United States. Gastroenterology 145 (2013), 375–382 e1−e2.
3. 3 Everhart, J.E., Ruhl, C.E., Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas. Gastroenterology 136 (2009), 1134–1144.
4. 4 Jemal, A., Bray, F., Center, M.M., et al. Global cancer statistics. CA Cancer J Clin 61 (2011), 69–90.
5. 5 Messina, J.P., Humphreys, I., Flaxman, A., et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 61 (2015), 77–87.
6. 6 Schweitzer, A., Horn, J., Mikolajczyk, R.T., et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386 (2015), 1546–1555.
7. 7 Ioannou, G.N., Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey. Ann Intern Med 154 (2011), 319–328.
8. 8 Younossi, Z.M., Koenig, A.B., Abdelatif, D., et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64 (2016), 73–84.
9. 9 Rehm, J., Samokhvalov, A.V., Shield, K.D., Global burden of alcoholic liver diseases. J Hepatol 59 (2013), 160–168.
10. 10 Bravo, A.A., Sheth, S.G., Chopra, S., Liver biopsy. N Engl J Med 344 (2001), 495–500.
11. 11 Seeff, L.B., Everson, G.T., Morgan, T.R., et al. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol 8 (2010), 877–883.
12. 12 Regev, A., Berho, M., Jeffers, L.J., et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97 (2002), 2614–2618.
13. 13 Castera, L., Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 142 (2012), 1293–1302.e4.
14. 14 Tapper, E.B., Castera, L., Afdhal, N.H., FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice. Clin Gastroenterol Hepatol 13 (2015), 27–36.
15. 15 Smith, B.D., Morgan, R.L., Beckett, G.A., et al. Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention. Ann Intern Med 157 (2012), 817–822.
16. 16 Sebastiani, G., Ghali, P., Wong, P., et al. Physicians’ practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey. Can J Gastroenterol Hepatol 28 (2014), 23–30.
17. 17 Kan, V.Y., Marquez Azalgara, V., Ford, J.A., et al. Patient preference and willingness to pay for transient elastography versus liver biopsy: a perspective from British Columbia. Can J Gastroenterol Hepatol 29 (2015), 72–76.
18. 18 European Association for Study of the Liver, Asociacion Latinoamericana para el Estudio del H. EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 63 (2015), 237–264.
19. 19 Castera, L., Pinzani, M., Bosch, J., Non invasive evaluation of portal hypertension using transient elastography. J Hepatol 56 (2012), 696–703.
20. 20 Rockey, D.C., Bissell, D.M., Noninvasive measures of liver fibrosis. Hepatology 43 (2006), S113–S120.
21. 21 Schunemann, H.J., Oxman, A.D., Brozek, J., et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 336 (2008), 1106–1110.
22. 22 Whiting, P.F., Rutjes, A.W., Westwood, M.E., et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155 (2011), 529–536.
23. 23 Castera, L., Foucher, J., Bernard, P.H., et al. Pitfalls of liver stiffness measurement: A 5-year prospective study of 13,369 examinations. Hepatology 51 (2010), 828–835.
24. 24 Ji, D., Shao, Q., Han, P., et al. The frequency and determinants of liver stiffness measurement failure: a retrospective study of “real-life” 38,464 examinations. PLoS ONE, 9, 2014, e105183.
25. 25 Sirli, R., Sporea, I., Bota, S., et al. Factors influencing reliability of liver stiffness measurements using transient elastography (M-probe)-monocentric experience. Eur J Radiol 82 (2013), e313–e316.
26. 26 Arena, U., Vizzutti, F., Corti, G., et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 47 (2008), 380–384.
27. 27 Sagir, A., Erhardt, A., Schmitt, M., et al. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 47 (2008), 592–595.
28. 28 Millonig, G., Reimann, F.M., Friedrich, S., et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 48 (2008), 1718–1723.
29. 29 Millonig, G., Friedrich, S., Adolf, S., et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol 52 (2010), 206–210.
30. 30 Gianni, E., Forte, P., Galli, V., et al. Prospective evaluation of liver stiffness using transient elastography in alcoholic patients following abstinence. Alcohol Alcohol 52 (2017), 42–47.
31. 31 Arena, U., Platon, M.L., Stasi, C., et al. Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution. Hepatology 58 (2013), 65–72.
32. 32 Rinella, M.E., Nonalcoholic fatty liver disease: a systematic review. JAMA 313 (2015), 2263–2273.
33. 33 Thein, H.H., Yi, Q., Dore, G.J., et al. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology 48 (2008), 418–431.
34. 34 Yim, H.J., Lok, A.S., Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43:Suppl 1 (2006), S173–S181.
35. 35 Schwartz, J.M., Reinus, J.F., Prevalence and natural history of alcoholic liver disease. Clin Liver Dis 16 (2012), 659–666.
36. 36 Crossan, C., Tsochatzis, E.A., Longworth, L., et al. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: Systematic review and economic evaluation. Health Technol Assess 19 (2015), 1–458.
37. 37 American Association for the Study of Liver Diseases-Infectious Diseases Society of American. Recommendations for testing, managing, and treating hepatitis C. http://www.hcvguidelines.org. Published 2016. Accessed June 1, 2016.
38. 38 Bota, S., Sporea, I., Peck-Radosavljevic, M., et al. The influence of aminotransferase levels on liver stiffness assessed by acoustic radiation force impulse elastography: a retrospective multicentre study. Digest Liver Dis 45 (2013), 762–768.
39. 39 Cardoso, A.C., Carvalho-Filho, R.J., Stern, C., et al. Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int 32 (2012), 612–621.
40. 40 Castera, L., Winnock, M., Pambrun, E., et al. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration. HIV Med 15 (2014), 30–39.
41. 41 D'Ambrosio, R., Aghemo, A., Fraquelli, M., et al. The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response. J Hepatol 59 (2013), 251–256.
42. 42 Lupsor Platon, M., Stefanescu, H., Feier, D., et al. Performance of unidimensional transient elastography in staging chronic hepatitis C. Results from a cohort of 1,202 biopsied patients from one single center. J Gastrointest Liver Dis 22 (2013), 157–166.
43. 43 Verveer, C., Zondervan, P.E., Ten Kate, F.J.W., et al. Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C. Liver Int 32 (2012), 622–628.
44. 44 Carrion, J.A., Navasa, M., Bosch, J., et al. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transplant 12 (2006), 1791–1798.
45. 45 Castera, L., Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. J Viral Hepat 16 (2009), 300–314.
46. 46 Degos, F., Perez, P., Roche, B., et al. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol 53 (2010), 1013–1021.
47. 47 De Ledinghen, V., Douvin, C., Kettaneh, A., et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. Journal of Acquir Immune Defic Syndr 41 (2006), 175–179.
48. 48 Gaia, S., Carenzi, S., Barilli, A.L., et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 54 (2011), 64–71.
49. 49 Gara, N., Zhao, X., Kleiner, D.E., et al. Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C. Clin Gastroenterol Hepatol 11 (2013), 303–308.e1.
50. 50 Liu, C.H., Liang, C.C., Huang, K.W., et al. Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients. Clin J Am Soc Nephrol 6 (2011), 1057–1064.
51. 51 Nitta, Y., Kawabe, N., Hashimoto, S., et al. Liver stiffness measured by transient elastography correlates with fibrosis area in liver biopsy in patients with chronic hepatitis C. Hepatol Res 39 (2009), 675–684.
52. 52 Patel, K., Friedrich-Rust, M., Lurie, Y., et al. FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus. World J Gastroenterol 17 (2011), 4581–4589.
53. 53 Sporea, I., Sirli, R., Deleanu, A., et al. Liver stiffness measurements in patients with HBV vs HCV chronic hepatitis: a comparative study. World J Gastroenterol 16 (2010), 4832–4837.
54. 54 Aleman, S., Rahbin, N., Weiland, O., et al. A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis. Clin Infect Dis 57 (2013), 230–236.
55. 55 Cassinotto, C., Lapuyade, B., Mouries, A., et al. Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan. J Hepatol 61 (2014), 550–557.
56. 56 Crisan, D., Radu, C., Grigorescu, M.D., et al. Prospective non-invasive follow-up of liver fibrosis in patients with chronic hepatitis C. J Gastrointest Liver Dis 21 (2012), 375–382.
57. 57 Seo, Y.S., Kim, M.Y., Kim, S.U., et al. Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: a multicentre, retrospective study. Liver Int 35 (2015), 2246–2255.
58. 58 Castera, L., Vergniol, J., Foucher, J., et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005), 343–350.
59. 59 Cho, H.J., Seo, Y.S., Lee, K.G., et al. Serum aminotransferase levels instead of etiology affects the accuracy of transient elastography in chronic viral hepatitis patients. J Gastroenterol Hepatol 26 (2011), 492–500.
60. 60 Obara, N., Ueno, Y., Fukushima, K., et al. Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases. J Gastroenterol 43 (2008), 720–728.
61. 61 Ziol, M., Handra-Luca, A., Kettaneh, A., et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41 (2005), 48–54.
62. 62 Xiao, G., Yang, J., Yan, L., Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology 61 (2015), 292–302.
63. 63 Terrault, N.A., Bzowej, N.H., Chang, K.M., et al. AASLD guidelines for treatment of chronic hepatitis B. Hepatology 63 (2016), 261–283.
64. 64 Wu, Y., Johnson, K.B., Roccaro, G., et al. Poor adherence to AASLD guidelines for chronic hepatitis B Management and treatment in a large academic medical center. Am J Gastroenterol 109 (2014), 867–875.
65. 65 Castera, L., Bernard, P.H., Le Bail, B., et al. Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers. Aliment Pharmacol Ther 33 (2011), 455–465.
66. 66 Chan, H.L.Y., Wong, G.L.H., Choi, P.C.L., et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 16 (2009), 36–44.
67. 67 Chen, Y.P., Liang, X.E., Dai, L., et al. Improving transient elastography performance for detecting hepatitis B cirrhosis. Digest Liver Dis 44 (2012), 61–66.
68. 68 Goyal, R., Mallick, S.R., Mahanta, M., et al. Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B. J Gastroenterol Hepatol 28 (2013), 1738–1745.
69. 69 Jia, J., Hou, J., Ding, H., et al. Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B. J Gastroenterol Hepatol 30 (2015), 756–762.
70. 70 Kongtawelert, P., Chanmee, T., Pothacharoen, P., et al. Diagnostic accuracy of liver stiffness measurement and serum hyaluronic acid for detecting liver fibrosis in chronic hepatitis B with respect to ALT levels. Asian Biomed 7 (2013), 609–617.
71. 71 Marcellin, P., Ziol, M., Bedossa, P., et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 29 (2009), 242–247.
72. 72 Kumar, M., Rastogi, A., Singh, T., et al. Analysis of discordance between transient elastography and liver biopsy for assessing liver fibrosis in chronic hepatitis B virus infection. Hepatol Int 7 (2013), 134–143.
73. 73 Lee, H.W., Kang, W., Kim, B.K., et al. Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B. Liver Int 36 (2016), 24–30.
74. 74 Papatheodoridis, G.V., Manolakopoulos, S., Margariti, A., et al. The usefulness of transient elastography in the assessment of patients with HBeAg-negative chronic hepatitis B virus infection. J Viral Hepat 21 (2014), 517–524.
75. 75 Trembling, P.M., Lampertico, P., Parkes, J., et al. Performance of Enhanced liver fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection. J Viral Hepat 21 (2014), 430–438.
76. 76 Wong, V.W.S., Lampertico, P., de Ledinghen, V., et al. Probability-based interpretation of liver stiffness measurement in untreated chronic hepatitis B patients. Digest Dis Sci 60 (2015), 1448–1456.
77. 77 Zhang, D., Chen, M., Wang, R., et al. Comparison of acoustic radiation force impulse imaging and transient elastography for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B. Ultrasound Med Biol 41 (2015), 7–14.
78. 78 Ogawa, E., Furusyo, N., Murata, M., et al. Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis B patients treated with nucleoside analog. Hepatol Res 41 (2011), 1178–1188.
79. 79 Wang, J.H., Changchien, C.S., Hung, C.H., et al. FibroScan and ultrasonography in the prediction of hepatic fibrosis in patients with chronic viral hepatitis. J Gastroenterol 44 (2009), 439–446.
80. 80 Chan, W.K., Nik Mustapha, N.R., Mahadeva, S., A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis. Hepatol Int 9 (2015), 594–602.
81. 81 Imajo, K., Kessoku, T., Honda, Y., et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology 150 (2016), 626–637 e7.
82. 82 Myers, R.P., Elkashab, M., Ma, M., et al. Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study. Can J Gastroenterol 24 (2010), 661–670.
83. 83 Kumar, R., Rastogi, A., Sharma, M.K., et al. Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease: diagnostic performance and clinicopathological correlation. Digest Dis Sci 58 (2013), 265–274.
84. 84 Mahadeva, S., Mahfudz, A.S., Vijayanathan, A., et al. Performance of transient elastography (TE) and factors associated with discordance in non-alcoholic fatty liver disease. J Digest Dis 14 (2013), 604–610.
85. 85 Myers, R.P., Pomier-Layrargues, G., Kirsch, R., et al. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. J Hepatol 56 (2012), 564–570.
86. 86 Wong, V.W.S., Vergniol, J., Wong, G.L.H., et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 107 (2012), 1862–1871.
87. 87 Wong, V.W.S., Vergniol, J., Wong, G.L.H., et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51 (2010), 454–462.
88. 88 Yoneda, M., Mawatari, H., Fujita, K., et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Digest Liver Dis 40 (2008), 371–378.
89. 89 Yoneda, M., Suzuki, K., Kato, S., et al. Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. Radiology 256 (2010), 640–647.
90. 90 Sun, W., Cui, H., Li, N., et al. Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: a meta-analysis study. Hepatol Res 46 (2016), 862–870.
91. 91 Singh, S., Allen, A.M., Wang, Z., et al. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol 13 (2015), 643–654 e1−e9; quiz e39−e40.
92. 92 Petta, S., Di Marco, V., Camma, C., et al. Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Aliment Pharmacol Ther 33 (2011), 1350–1360.
93. 93 Pavlov, C.S., Casazza, G., Nikolova, D., et al. Systematic review with meta-analysis: diagnostic accuracy of transient elastography for staging of fibrosis in people with alcoholic liver disease. Aliment Pharmacol Ther 43 (2016), 575–585.
94. 94 Bardou-Jacquet, E., Legros, L., Soro, D., et al. Effect of alcohol consumption on liver stiffness measured by transient elastography. World J Gastroenterol 19 (2013), 516–522.
95. 95 Boursier, J., Vergniol, J., Sawadogo, A., et al. The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis. Liver Int 29 (2009), 1507–1515.
96. 96 De Ledinghen, V., Wong, V.W.S., Vergniol, J., et al. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan. J Hepatol 56 (2012), 833–839.
97. 97 Dolman, G.E., Nieboer, D., Steyerberg, E.W., et al. The performance of transient elastography compared to clinical acumen and routine tests—what is the incremental diagnostic value?. Liver Int 33 (2013), 172–179.
98. 98 Lannerstedt, H., Konopski, Z., Sandvik, L., et al. Combining transient elastography with FIB4 enhances sensitivity in detecting advanced fibrosis of the liver. Scand J Gastroenterol 48 (2013), 93–100.
99. 99 Mueller, S., Millonig, G., Sarovska, L., et al. Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J Gastroenterol 16 (2010), 966–972.
100. 100 Kim, S.G., Kim, Y.S., Jung, S.W., et al. [The usefulness of transient elastography to diagnose cirrhosis in patients with alcoholic liver disease]. Korean J Hepatol 15 (2009), 42–51.
101. 101 Calvaruso, V., Bronte, F., Conte, E., et al. Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis. J Viral Hepat 20 (2013), 867–874.
102. 102 Castera, L., Bail, B.L., Roudot-Thoraval, F., et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol 50 (2009), 59–68.
103. 103 Kazemi, F., Kettaneh, A., N'Kontchou, G., et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 45 (2006), 230–235.
104. 104 Nguyen-Khac, E., Saint-Leger, P., Tramier, B., et al. Noninvasive diagnosis of large esophageal varices by fibroscan: strong influence of the cirrhosis etiology. Alcoholism Clin Exp Res 34 (2010), 1146–1153.
105. 105 Pineda, J.A., Recio, E., Camacho, A., et al. Liver stiffness as a predictor of esophageal varices requiring therapy in HIV/hepatitis C virus-coinfected patients with cirrhosis. J Acquir Immune Defic Syndr 51 (2009), 445–449.
106. 106 Pritchett, S., Cardenas, A., Manning, D., et al. The optimal cutoff for predicting large oesophageal varices using transient elastography is disease specific. J Viral Hepat 18 (2011), e75–e80.
107. 107 Vermehren, J., Polta, A., Zimmermann, O., et al. Comparison of acoustic radiation force impulse imaging with transient elastography for the detection of complications in patients with cirrhosis. Liver Int 32 (2012), 852–858.
108. 108 Wang, H.M., Lo, G.H., Chen, W.C., et al. Efficacy of transient elastography in screening for large esophageal varices in patients with suspicious or proven liver cirrhosis. J Digest Dis 13 (2012), 430–438.
109. 109 de Franchis, R., Baveno, V.I.F., Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 63 (2015), 743–752.
110. 110 Garcia-Tsao, G., Sanyal, A.J., Grace, N.D., et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 46 (2007), 922–938.
111. 111 Al-Dahshan, M., Clinical application of transient elastography in prediction of portal hypertension related complication in patients with chronic liver diseases. J Egypt Soc Parasitol 42 (2012), 79–88.
112. 112 Bintintan, A., Chira, R.I., Bintintan, V.V., et al. Value of hepatic elastography and Doppler indexes for predictions of esophageal varices in liver cirrhosis. Med Ultrason 17 (2015), 5–11.
113. 113 Colecchia, A., Montrone, L., Scaioli, E., et al. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. Gastroenterology 143 (2012), 646–654.
114. 114 Fraquelli, M., Giunta, M., Pozzi, R., et al. Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis. J Viral Hepat 21 (2014), 90–98.
115. 115 Stefanescu, H., Grigorescu, M., Lupsor, M., et al. Spleen stiffness measurement using fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients. J Gastroenterol Hepatol 26 (2011), 164–170.
116. 116 Vizzutti, F., Arena, U., Romanelli, R.G., et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 45 (2007), 1290–1297.
117. 117 Telem, D.A., Schiano, T., Goldstone, R., et al. Factors that predict outcome of abdominal operations in patients with advanced cirrhosis. Clin Gastroenterol Hepatol 8 (2010), 451–457 quiz e58.
118. 118 Teh, S.H., Nagorney, D.M., Stevens, S.R., et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 132 (2007), 1261–1269.
119. 119 Singh, S., Venkatesh, S.K., Wang, Z., et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol 13 (2015), 440–451.
120. 120 Stewart, L.A., Parmar, M.K., Meta-analysis of the literature or of individual patient data: is there a difference?. Lancet 341 (1993), 418–422.
121. 121 Park, C.C., Nguyen, P., Hernandez, C., et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology 152 (2017), 598–607e2.
122. 122 Chalasani, N., Younossi, Z., Lavine, J.E., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142 (2012), 1592–1609.